No Data
No Data
Express News | The surge in subscription multiples is frequently seen; the Hong Kong stock market is hot for new listings.
This week's Hong Kong stock market bulls | The escalation of the situation in the Middle East has driven oil and gas stocks to surge, with SINOPEC SSC rising 25% on Friday; pharmaceutical stocks are performing well, with LUYE PHARMA increasing over 33% du
This week, the Hang Seng Index has risen by 0.42%, closing at 23,892.56 points; during the same period, the Hang Seng TECH Index has decreased by 0.89%, closing at 5,239.71 points; the Hang Seng China Enterprises Index has risen by 0.3%, closing at 8,655.33 points.
Yingen Biotech (09606.HK) presented the results of two studies at the 2025 American Society of Clinical Oncology oral presentations.
Yingen Biotechnology-B (09606.HK) has issued a statement regarding recent fluctuations in stock price and Volume. The company published a news article on its website on June 5, detailing two research results presented in a verbal report on ADC candidates HER3 ADC DB-1310 and B7H3 ADC DB-1311/BNT324 at the 2025 American Society of Clinical Oncology (ASCO) annual meeting. Preliminary data indicate early clinical activity and controllable safety characteristics, with a low rate of treatment discontinuation. The most common adverse events are gastrointestinal and hematologic toxicity, requiring clinical management.
The stock price of Mingen Biotech-B (09606.HK) is experiencing unusual fluctuations. The information contained in the news article does not constitute insider information.
On June 10, Gelonghui reported that the Board of Directors of Wintech Bio-B (09606.HK) has learned about the recent fluctuations in the Fill Price and Volume of the company's shares on the Hong Kong Stock Exchange on June 9 and June 10, 2025. The Board also noted that on June 5, 2025, the company published a news article on its website regarding the preliminary data of its ADC candidate drug presented in a verbal report at the 2025 American Society of Clinical Oncology (ASCO) annual meeting. After making all reasonable inquiries regarding the company in this context, the Board confirms that (i) regarding...
Hong Kong stock midday review | The three major indices are mixed, with the Hang Seng Index up 0.33%; airline and pharmaceutical stocks performed well, with China Eastern Airlines rising nearly 5% and 3SBIO rising over 11%.
The Network Technology stocks are adjusting, Bilibili-W rose by 1.93%, MEITUAN-W fell by 1.48%; sports equipment stocks are all rising, 361 DEGREES rose by 4.20%, LI NING rose by 2.93%; the dining stocks are all going up, JIUMAOJIU rose by 7.11%, and Xiaocaiyuan rose by 3.95%.
Hong Kong Stock Market Afternoon Review | Hang Seng Index rose 0.33% in the morning session, with the banking sector continuing its upward trend.
Insurance funds continue to increase their shareholding in China Mainland Banking. Institutions claim that there is still significant room for valuation recovery in Hong Kong Bank stocks.